A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS)

NCT02024789 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

173

Enrollment

INDUSTRY

Sponsor class

Conditions

Down Syndrome

Interventions

DRUG: Placebo
DRUG: RG1662
DRUG: RG1662

Sponsor

Hoffmann-La Roche